To our knowledge, no data on intra-abdominal fluconazole exposure in LTx patients have been published. Here we report on the intra-abdominal penetration and pharmacodynamic exposure in three LTx patients who had documented intra-abdominal candidiasis (cholangitis in Patients 1 and 2; peritonitis in Patient 3) treated with fluconazole

Intra-abdominal penetration and pharmacodynamic exposure to fluconazole in three liver transplant patients with deep-seated candidiasis

Righi E;Carnelutti A;
2014-01-01

Abstract

To our knowledge, no data on intra-abdominal fluconazole exposure in LTx patients have been published. Here we report on the intra-abdominal penetration and pharmacodynamic exposure in three LTx patients who had documented intra-abdominal candidiasis (cholangitis in Patients 1 and 2; peritonitis in Patient 3) treated with fluconazole
2014
Fluconazole, TDM, liver transplant
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/993405
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 22
  • ???jsp.display-item.citation.isi??? 21
social impact